Clinical Trial Update: Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of epratuzumab in combination with rituximab for previously untreated follicular non-Hodgkin lymphoma completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Non-hodgkin Lymphoma

Drugs mentioned

• Epratuzumab (epratuzumab)
• Rituximab (rituximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-07-24